Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07804524 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Assessment of Total Pulmonary Resistance sPAP/CO Between High Altitude HA vs. Sea Level LA in Patients With Pulmonary Arterial Hypertension PAH

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 4, 2026 (before its estimated October 4, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
To study the effect of relocation from high altitude (Quito Ecuador: 2850m) to sea level on pulmonary resistance (sPAP/CO) and other hemodynamic outcomes in patients with pulmonary arterial hypertension PAH, who live permanently \>2600m.
Trial Details
NCT Number NCT07804524
Lead Sponsor Silvia Ulrich Somaini
Conditions
(from sponsor)		 Pulmonary Arterial Hypertension (PAH), Pulmonary Vascular Disease, High Altitude, Echocardiography, Pulmonary Resistance, Hemodynamic Changes
Related terms Altitude Sickness, Hypertension, Pulmonary, Hypoxia, Pulmonary Arterial Hypertension
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov